Review on MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)), with data on DNA, on the protein encoded, and where the gene is implicated
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While the pathways that are...
AbstractDysregulated expression of MYC family genes is a hallmark of many malignancies. Unfortunatel...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
Review on MYCN (myc myelocytomatosis viral related oncogene, neuroblastoma derived), with data on DN...
Review on MYC (v-myc myelocytomatosis viral oncogene homolog (avian)), with data on DNA, on the prot...
Background: Neuroblastoma is the most common extracranial solid tumor in children. MYCN gene amplifi...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
BACKGROUND: MYCN oncogene amplification has been defined as the most important prognostic factor for...
Neuroblastoma is a highly genetically heterogeneous form of paediatric cancer with clinical behaviou...
Background Amplified MYCN oncogene resulting in deregulated MYCN transcriptional activity is observe...
Neuroblastoma is an embryonic tumor arising from immature sympathetic nervous system cells. Recurren...
Amplification of the locus encoding the oncogenic transcription factor MYCN is a defining feature of...
Neuroblastoma is the first neurogenic-extracranial solid cancer occurring in infancy and childhood. ...
Although the MYC oncogene has been implicated in cancer, a systematic assessment of alterations of M...
MYC is the most altered oncogene in human cancer, and belongs to a large family of genes, including ...
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While the pathways that are...
AbstractDysregulated expression of MYC family genes is a hallmark of many malignancies. Unfortunatel...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
Review on MYCN (myc myelocytomatosis viral related oncogene, neuroblastoma derived), with data on DN...
Review on MYC (v-myc myelocytomatosis viral oncogene homolog (avian)), with data on DNA, on the prot...
Background: Neuroblastoma is the most common extracranial solid tumor in children. MYCN gene amplifi...
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article dis...
BACKGROUND: MYCN oncogene amplification has been defined as the most important prognostic factor for...
Neuroblastoma is a highly genetically heterogeneous form of paediatric cancer with clinical behaviou...
Background Amplified MYCN oncogene resulting in deregulated MYCN transcriptional activity is observe...
Neuroblastoma is an embryonic tumor arising from immature sympathetic nervous system cells. Recurren...
Amplification of the locus encoding the oncogenic transcription factor MYCN is a defining feature of...
Neuroblastoma is the first neurogenic-extracranial solid cancer occurring in infancy and childhood. ...
Although the MYC oncogene has been implicated in cancer, a systematic assessment of alterations of M...
MYC is the most altered oncogene in human cancer, and belongs to a large family of genes, including ...
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While the pathways that are...
AbstractDysregulated expression of MYC family genes is a hallmark of many malignancies. Unfortunatel...
none9siA wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is asso...
DOI
Add to ORKG